Clinical trial
Fetched
Post
clinicaltrials.gov
Andrew Zimmerman, Johns Hopkins University
(2011).
Sulforaphane-rich Broccoli Sprout Extract for Autism.
ClinicalTrials.gov.
Andrew Zimmerman.
- Publication date
-
2011
- Identifier
-
NCT01474993
- Authors
-
Andrew Zimmerman,
Johns Hopkins University
- Source
- ClinicalTrials.gov
- Reference type
- clinical_trial
- Publisher
- Andrew Zimmerman
- Metadata source
- clinicaltrials.gov
Abstract
The primary objectives of this study are to answer whether there is evidence of measurable effects on social responsiveness (primary outcome) and other behavioral symptoms after treatment of autistic male adolescents and adults with orally administered sulforaphane-rich Broccoli Sprout Extract (efficacy). The secondary objectives of this study are to answer whether treatment of male adolescents and adults with autism using orally administered sulforaphane-rich Broccoli Sprout Extract within a specified dose range is safe (toxicity); treatment with sulforaphane-rich Broccoli Sprout Extract is well tolerated (side effects and adverse events); key cellular biomarkers support the hypothesized mechanisms (proof of principle).